Insights into Company Bills & Payments

Anik Industries Limited

📍 Mumbai, Maharashtra, India Active NSE ANIKINDS CIN L24118MH1976PLC136836
Search companies

Key Metrics of Anik Industries Limited

Revenue₹144 Cr▲ 23.8% YoYFY 2025-26
EBITDA₹4.29 Cr▼ 22.9% YoY
Net profit₹1.57 Cr▼ 59.5% YoY
Net worth₹287 Cr▲ 0.6% YoY

About Anik Industries Limited

Company details

Registered office
610, Tulsiani Chambers Nariman Point, Mumbai, In-mh, 400021
Listed
NSE: ANIKINDS · ₹39.74

Company summary

Entity details

CINL24118MH1976PLC136836
LEI code335800YHZVMEPYQF4Z09
State codeMH
PIN code400021
Current legal nameANIK INDUSTRIES LIMITED
Classification—
Listing statusListed (NSE: ANIKINDS)
Registration no.136836
Company age—
PAN—
CountryIndia
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code24118
Description of main activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
Description of business activityManufacture of chemicals and chemical products (incl. pharmaceuticals)
SectorOther Industries · Discovered Companies

Share price · NSE: ANIKINDS

ANIKINDS on NSE

Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 0 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 29 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 29 Nov 2023 Withdrawn Withdrawn
Change in last 12 monthsNo change
Change since first rating on record▼ 9 notchessince Feb 2019
Rating actions80 up · 0 down

NoteLatest action: rating withdrawn (CARE, 29 Nov 2023)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
29 Nov 2023CAREWithdrawn D——— View
01 Sep 2022CARENon-cooperating D——₹78.0 Cr View
21 Jul 2021CARENon-cooperating D——₹480 Cr View
19 Jun 2020CARENon-cooperating D——₹480 Cr View
21 Aug 2019CARENon-cooperating DA4—₹240 Cr View
09 Jul 2019CARENon-cooperating CA4Stable₹240 Cr View
15 Mar 2019CARENon-cooperating (from BB+) B+A4Stable₹240 Cr View
18 Feb 2019CAREWatch BB+A4—₹240 Cr View

Credit strengths (CARE, Sep 2022)

—

Credit challenges

− On-going delays in debt servicing

As per results published on stock exchange for quarter ended June 30, 2022, there has been instance of Letter of Credit (LC) devolvement. Furthermore, one of the lenders also informed that there were instances of LC devolvement in the month of June and August 2022.

Could lead to an upgrade

• The ability of the company to meet its debt obligation in timely manner for a period of at least consecutive t hree months.

Agency-reported financials (CARE, 29 Nov 2023)

MetricMarch 31, 2022March 31, 2023H1FY24
Total operating income₹244 Cr₹118 Cr₹32.92 Cr
PBILDT₹2.53 Cr₹5.88 Cr₹5.00 Cr
PAT₹10.03 Cr₹5.07 Cr₹3.20 Cr
Overall gearing (times)0.15×0.11×0.03×
Interest coverage (times)0.37×1.64×5.49×
Revenue growth (YoY)—−51.5%—
EBITDA margin1.0%5.0%15.2%
Implied interest cost (EBITDA ÷ coverage)₹6.84 Cr₹3.59 Cr₹0.91 Cr
PAT margin4.1%4.3%9.7%

Borrowings & rated debt

Rated borrowing limits (latest)₹78.0 Cr
Peak rated limits₹480 CrJun 2020 · CARE
Limits raised0 times0 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long Term Bank FacilitiesWorking capital & bank lines—₹10.0 Cr— DNon-cooperatingCARE
Short Term Bank FacilitiesWorking capital & bank lines—₹68.0 Cr— DNon-cooperatingCARE

CARE ratings on record (checked 22 Oct 2026)

InstrumentAmountRating
Long Term—Withdrawn
Short Term—Withdrawn
Working Capital Demand loan—Withdrawn

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionNegative
CARE rating · Sep 2022DMatches indicative band

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultIn default (CARE D)
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
WithdrawalCARE · 29 Nov 2023 · Withdrawn at company request with lender NOCs
Next action stable or better (model)24%
Information on file67% · missing: Capex / investment plans, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 24% (Downgrade likely) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹78.00 Cr
Not yet allocated—
Extra debt within 2.5× EBITDA—
Interest coverage14.48×
Limit utilisation—
Open bank charges0 · —
  • Credit outlook model: 24% chance the next rating action is stable or better
  • Current rating D (below investment grade)
  • Interest coverage 14.48×
  • Issuer not cooperating with the rating agency
  • CARE withdrew its ratings on 29 Nov 2023 — usually after the rated bank loans were repaid or moved to another lender

Rated limits by facility

Timeline

29 Nov 2023 CARE withdrawn: D CARE rationale
29 Nov 2023 Full repayment of debt
From the report

Analytical approach: Standalone Detailed description of the key rating drivers: Key weaknesses Delays in debt servicing: As per AIL’s annual report for FY23, the company had defaulted in repayments of its debt obligations.

CARE rationale
01 Sep 2022 CARE non-cooperating: DRated limits ₹78 cr CARE rationale
21 Jul 2021 CARE non-cooperating: DRated limits ₹480 cr CARE rationale
19 Jun 2020 CARE non-cooperating: DRated limits ₹480 cr CARE rationale
21 Aug 2019 CARE non-cooperating: DRated limits ₹240 cr CARE rationale
09 Jul 2019 CARE non-cooperating: C (Stable)Rated limits ₹240 cr CARE rationale
15 Mar 2019 CARE non-cooperating: B+ (Stable)Rated limits ₹240 cr CARE rationale
18 Feb 2019 CARE watch: BB+Rated limits ₹240 cr CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered office610, TULSIANI CHAMBERS NARIMAN POINT, MUMBAI, IN-MH, 400021
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.